Permanent cardiac pacing in patients on chronic renal dialysis |
| |
| Authors: | Robert B Leman MD John M Kratz MD Peter C Gazes MD |
| |
| Institution: | 1. Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Austria;2. Berlin Eye Research Institute and Eyeclinic Spreebogen, Berlin, Germany;1. UOL di Genetica Medica, Dipartimento di Riproduzione ed Accrescimento e Dipartimento di Scienze Mediche, Università di Ferrara, via Fossato di Mortara, 74, 44121 Ferrara, Italy;2. Sezione di Genetica Medica- Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università di Genova, L.go P. Daneo, 3, 16132 Genova, Italy;3. IST-UOC Genetica Medica- IRCCS AOU San Martino, Largo Rosanna Benzi, 10, Genova, Italy;4. UILDM (Unione Italiana Lotta alla Distrofia Muscolare), Via A. Berardi, n. 51, 37139 Verona, Italy;1. School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China;2. Qianjiang Central Hospital of Chongqing, Chongqing 409099, China;1. Department of Medicine, Cambridge Health Alliance, Harvard Medical School, 1493 Cambridge St, Cambridge, MA 02139, USA;2. Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, USA;3. Department of Medicine, Manipal University, Manipal, Karnataka, India;4. Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA;1. University Clinical Hospital of Santiago de Compostela, Cardiology Department, Santiago de Compostela, Spain;2. University Clinical Hospital of Santiago de Compostela, Anesthesiology Department, Santiago de Compostela, Spain;1. Division of Angiology and Haemostasis, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland;2. Centre Hospitalier Universitaire Clermont-Ferrand, Service d''hématologie biologique, Hôpital Estaing, Clermont-Ferrand, France;3. Department of Genetic Medicine and Development, University Medical School of Geneva, Geneva, Switzerland;4. Institut Hématologie Transfusion, Pôle Biologie Pathologie Génétique, Centre Hospitalier Regional Universitaire, Lille, France;5. Department of Biology and Haematology, Centre Hospitalier Universitaire Dijon, Dijon, France;6. Centre de Traitement Régional de l''Hémophilie, Centre Hospitalier Universitaire Caen, Caen, France;7. Haemostasis Laboratory, Hôpital Saint Eloi, Montpellier, France |
| |
| Abstract: | We reviewed the need for permanent pacemaker implantation in patients with chronic renal failure who were undergoing dialysis. During a 10-year span, there were seven patients undergoing dialysis in whom a permanent pacemaker was indicated; this was an incidence of 0.68%. During that same period, the general patient population of this hospital had an incidence of permanent pacemaker implantation of about 0.29%. The need for hemodialysis in the same hospital population was 0.51%. Of the seven patients, four had universal pacemakers. Cardiac function was evaluated via radionuclide angiography. Three of the four patients showed improvement with dual-chambered pacing over ventricular pacing. Permanent pacemaker implantation was often needed after initiation of dialysis from 6 to 51 months with a mean of 21 months. During the follow-up period, three patients died from 7 months to 6 years after the institution of permanent pacing; their deaths were secondary to renal disease. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
